Speece Thorson Capital Group Inc. Sells 142 Shares of Teleflex Incorporated (NYSE:TFX)

Speece Thorson Capital Group Inc. lessened its stake in Teleflex Incorporated (NYSE:TFX) by 0.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 47,904 shares of the medical technology company’s stock after selling 142 shares during the period. Teleflex accounts for 2.2% of Speece Thorson Capital Group Inc.’s portfolio, making the stock its 26th largest holding. Speece Thorson Capital Group Inc.’s holdings in Teleflex were worth $11,848,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently bought and sold shares of the stock. Janus Henderson Group PLC lifted its stake in shares of Teleflex by 12.0% in the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company’s stock valued at $1,223,424,000 after purchasing an additional 581,312 shares during the period. Point72 Asset Management L.P. lifted its stake in shares of Teleflex by 564.3% in the 2nd quarter. Point72 Asset Management L.P. now owns 310,484 shares of the medical technology company’s stock valued at $65,304,000 after purchasing an additional 263,743 shares during the period. Cooke & Bieler LP lifted its stake in shares of Teleflex by 23.3% in the 2nd quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company’s stock valued at $191,989,000 after purchasing an additional 172,335 shares during the period. Ceredex Value Advisors LLC acquired a new position in shares of Teleflex in the 2nd quarter valued at $25,550,000. Finally, National Bank of Canada FI lifted its stake in shares of Teleflex by 1,008.2% in the 2nd quarter. National Bank of Canada FI now owns 115,343 shares of the medical technology company’s stock valued at $24,388,000 after purchasing an additional 104,935 shares during the period. Institutional investors own 95.62% of the company’s stock.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of the firm’s stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $238.93, for a total value of $638,898.82. Following the completion of the sale, the director now directly owns 5,496 shares in the company, valued at approximately $1,313,159.28. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. 1.43% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently commented on the stock. Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Friday, November 1st. Mizuho lowered their price objective on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research report on Friday, November 1st. Truist Financial restated a “hold” rating and issued a $227.00 price objective (down previously from $255.00) on shares of Teleflex in a research report on Monday, November 4th. Finally, StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Tuesday. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $259.25.

Teleflex Stock Up 0.3 %

Shares of NYSE TFX traded up $0.61 during mid-day trading on Wednesday, hitting $196.19. The company had a trading volume of 19,636 shares, compared to its average volume of 376,267. The company has a market capitalization of $9.11 billion, a PE ratio of 38.88, a price-to-earnings-growth ratio of 2.03 and a beta of 1.18. The firm has a 50-day simple moving average of $234.45 and a two-hundred day simple moving average of $223.81. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a one year low of $194.58 and a one year high of $257.85.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. The company had revenue of $764.40 million during the quarter, compared to analysts’ expectations of $768.68 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Teleflex’s revenue for the quarter was up 2.4% compared to the same quarter last year. During the same quarter last year, the company earned $3.64 EPS. On average, equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Friday, November 15th will be issued a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.69%. The ex-dividend date of this dividend is Friday, November 15th. Teleflex’s payout ratio is 27.04%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.